Print

Purpose

To our knowledge, no other human studies directly compare the effectiveness of the various ablative technologies. We set out to design a study to directly compare ablative energy sources and evaluate their ability to destroy native endometriosis tissue in humans.

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adult women 18 years of age or older - Already planning to undergo scheduled robotic assisted or laparoscopic excision of lesions for pelvic pain symptoms (pelvic pain, dysmenorrhea, dyspareunia, dysuria, dyschezia, ovarian pain) or endometriosis of any kind (endometriosis of any location, or endometrioma)

Exclusion Criteria

  • Known pregnancy at enrollment or at the time of the excision surgery

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)
Masking Description
Pathologist is blinded to treatment arm

Arm Groups

ArmDescriptionAssigned Intervention
Active Comparator
Diathermy
  • Device: Diathermy
    Diathermy will be used to ablate the randomized sample.
Active Comparator
CO2 Laser
  • Device: CO2 Laser
    CO2 Laser will be used to ablate the randomized sample.
Active Comparator
Argon Beam Coagulator
  • Device: Argon Beam Coagulator
    Argon Beam Coagulator will be used to ablate the randomized sample.

Recruiting Locations

Good Samaritan Hospital
Cincinnati, Ohio 45220
Contact:
Devin Namaky, MD
513-862-1888
devin_namaky@trihealth.com

More Details

Status
Recruiting
Sponsor
TriHealth Inc.

Study Contact

Devin Namaky, MD
513-862-1888
devin_namaky@trihealth.com

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.